Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab with CHOP and ESHAP in PTCL
NCT00930605Phase 2Completed
- Start
- Jan 2005
- Primary completion
- Nov 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in peripheral T-cell lymphoma (PTCL). Started Jan 2005; status: completed.
02
Drugs
alemtuzumab
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00930605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930605.